HomeGLSI • NASDAQ
add
Greenwich Lifesciences Inc
Previous close
$9.43
Day range
$9.50 - $9.72
Year range
$8.06 - $18.75
Market cap
129.14M USD
Avg Volume
40.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.28M | 29.37% |
Net income | -3.26M | -31.75% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.28M | -29.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.75M | -50.06% |
Total assets | 2.75M | -50.08% |
Total liabilities | 1.44M | 269.22% |
Total equity | 1.31M | — |
Shares outstanding | 13.37M | — |
Price to book | 94.30 | — |
Return on assets | -239.78% | — |
Return on capital | -426.68% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.26M | -31.75% |
Cash from operations | -1.83M | -2.91% |
Cash from investing | — | — |
Cash from financing | 492.42K | 64.63% |
Net change in cash | -1.34M | 9.53% |
Free cash flow | -627.55K | 29.89% |
About
Founded
2006
Headquarters
Website
Employees
4
